1. Home
  2. TSEM vs MDGL Comparison

TSEM vs MDGL Comparison

Compare TSEM & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tower Semiconductor Ltd.

TSEM

Tower Semiconductor Ltd.

HOLD

Current Price

$220.81

Market Cap

12.4B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$518.14

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSEM
MDGL
Founded
1993
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4B
12.1B
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
TSEM
MDGL
Price
$220.81
$518.14
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$161.75
$674.45
AVG Volume (30 Days)
2.5M
261.6K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$19.21
$58.39
Revenue Next Year
$26.62
$48.55
P/E Ratio
$66.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.43
$265.00
52 Week High
$228.73
$615.00

Technical Indicators

Market Signals
Indicator
TSEM
MDGL
Relative Strength Index (RSI) 63.81 53.02
Support Level $111.97 $503.93
Resistance Level $228.73 $539.17
Average True Range (ATR) 14.15 15.73
MACD -2.90 -3.53
Stochastic Oscillator 82.64 38.62

Price Performance

Historical Comparison
TSEM
MDGL

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: